Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Theralase Announces Warrant Extension

<< Previous

Bullboard Posts

Next >>

Comment by Longholder99on Jan 09, 2021 3:33pm

184 Views

Post# 32261756

RE:Theralase Announces Warrant Extension

They did this a while back on some other warrants if memory serves. If it wasnt for C19 im sure the 50c warrants could be in the money by now as we wouldnt have had these delays due to jammed up Healthcare. Americans probably wouldve been treated and more results on the horizon. Managing a micro cap bio tech cant be easy in this environment. 2yr is just a nice long runway IMO. Letting them die would be bad for business.

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks